Associate Professor, Global Health
University of London, PhD, MSc
Albert Ludwigs University
- Office: Crosstown Center, CT 363
- Phone: (617) 414-1440
- Email: email@example.com
Veronika J. Wirtz, MSc, PhD is a pharmacist, educator and researcher with over ten years of experience in international public health focusing on health system strengthening and program evaluations of medicines access and utilization. Currently, Dr. Wirtz is Associate Professor of Global Health at Boston University School of Public Health (BUSPH) where she teaches courses in health systems, pharmaceuticals in public health, and non-communicable diseases. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico and coordinator of a student exchange program between the institutions of her affiliation.
Her interest and expertise include medicines price analysis, generic medicines policies, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.
Recently she became the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission has the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission is expected to be published in 2016.
From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.
She has worked as a technical advisor for various international organizations, among them the World Health Organization, the Pan American Health Organization, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health.
She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.
- Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS): Mapping the insulin market from different angles
- Flagship Report: Medicines in Universal Health Coverage
- International Assessment of Remuneration Models for Hospital and Community Pharmacy
- Lancet Commission on Essential Medicines Policies
- World Health Organization (WHO) Collaborating Center in Pharmaceutical Policy
Challenges of medicines management in the public and private sector under Ghana’s National Health Insurance Scheme – A qualitative study
BioMed Central. 2016 Feb;.
Bulletin of the WHO. 2015 Aug; 93:693-699.
The Market Dynamics of Generic Medicines in the Private Sector of 19 Low and Middle Income Countries between 2001 and 2011: A Descriptive Time Series Analysis
PLoS One. 2013 Sep; 8(9):1-11.
Health Policy and Planning. 2013 Jan; 28(1):1-10.
Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation
BMC Public Health. 2013 Jan; 12(1051).
Value in Health. 2013 Jan; 15(5):593-603.
Cadernos de Saúde Pública. 2012 Dec; 28(12):2245-2256.
A New Entity for the Negotiation of Public Procurement Prices for Patented Medicines in Mexico Lessons from the Field
World Health Organization Bulletin. 2012 Oct; 90:788-792.
Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico
World Health Organization Bulletin. 2012 Oct; 90:782-787.
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010
Health Policy. 2012 Jul; 106(3):211-224.
Allocating Scarce Financial Resources for HIV Treatment: Benchmarking Prices of Antiretroviral Medicines in Latin America
Health Policy and Planning. 2011 Dec; 1-11.